Skip to main content

Nigeria coronavirus: chloroquine trials to go ahead - NAFDAC

The director of Nigeria’s National Agency for Food and Drug Administration and Control (Nafdac), Mojisola Adeyeye, has disclosed that clinical trails for virus treatment using chloroquine will continue despite a recent move by the WHO to suspend a similar trial over safety concerns.
She told a local broadcaster that even though Nafdac did not dispute WHO’s conclusions, the decision to continue with the trial was in order to generate their own data.
“I do not know the data that they’re looking at, whether it’s from the Caucasian population or from the African population. If the data they’re looking at and the reason for suspending the trials is from Caucasian population, then it may be justified.
“But I don’t think we have data from the African population yet, because our genetic make up is different,” she added. Lagos State had announced last week that trials were to start with the anti-malarial drug. READ MORE

Comments

Popular posts from this blog

Russia displays its naval power

Russia's President Vladimir Putin (centre) walks with officials as he attends  a ceremony for Russia's Navy Day in Saint Petersburg on July 30, 2017 (AFP Photo/Alexey NIKOLSKY) President Vladimir Putin on Sunday oversaw a pomp-filled display of Russia's naval might as the Kremlin paraded its sea power from the Baltic Sea to the shores of Syria. Some 50 warships and submarines were on show along the Neva River and in the Gulf of Finland off the country's second city of Saint Petersburg after Putin ordered the navy to hold its first ever parade on such a grand scale. "Today much is being done to develop and modernise the navy," Putin told servicemen after surveying the military hardware from his presidential cutter. "The navy is not only dealing with its traditional tasks but also responding with merit to new challenges, making a significant contribution to the fight against terrorism and piracy." Read more

China getting serious with its science reputation, cracks down on fraudulent peer-review process

A massive peer-review fraud has triggered a tough response from the Chinese government. Officials last week announced that more than 400 researchers listed as authors on some 100 now-retracted papers will face disciplinary action because their misconduct has seriously damaged China’s scientific reputation. Some institutions have barred the scientists linked to the fraud from pursuing their research, at least temporarily. And they have imposed other penalties, including canceling promotions, honors, and grants. Government ministries have also announced new “zero tolerance” policies aimed at stamping out research fraud. "We should eradicate the problem from its roots," said He Defang, director of the Ministry of Science and Technology’s (MOST’s) regulatory division in Beijing. Although China has previously cracked down on scientific misconduct, a chronic problem. These penalties "are the harshest ever," says Chen Bikun, an information scientist at the Nanjing